Skip to main content
IN THE KNOW

Resources.

Category

TOPICS

Client news
MedImpact’s 2019 Annual Trend Report
A variety of factors influence the prescription drug costs for payers across the nation, including pharmaceutical companies’ pricing strategies, costs of cutting-edge therapies, the small number of individuals that some orphan drugs treat, and competition from generics and other therapies.
READ MORE
Client news
Lisa Haw receives AMCP’s Residency Director/Preceptor Award
The Academy of Managed Care Pharmacy (AMCP) recently named MedImpact’s Lisa Haw, PharmD, Principal of Clinical Account Management, the recipient of its Managed Care Pharmacy Residency Director/Preceptor Award.
READ MORE
Press releases
MedImpact earns URAC accreditation, 100% score across all pharmacy benefit management quality standards.
Perfect score highlights company’s commitment to clinical, operational excellence, and customer service
READ MORE
Press releases
MedImpact launches new solution that uses genetic testing to end “trial and error” prescribing.
Industry’s first “any drug, any time, any prescriber” approach to pharmacogenomics improves safety, lowers costs
READ MORE
Press releases
MedImpact receives three-year NCQA reaccreditation.
Commitment to high quality standards and rigorous process assessment results in 100% score
READ MORE
Press releases
MedImpact’s Managed Care Residency Program Receives 8-year Accreditation.
After extensive evaluation, the American Society of Health-System Pharmacists accredits MedImpact’s program for full term
READ MORE
Press releases
MedImpact celebrates 30 years making pharmacy benefits transparent, understandable, and affordable.
At a time of rapid vertical integration in the industry, MedImpact remains independent and member-focused
READ MORE
Client news
MedImpact leverages advanced technology and network solutions to improve member experience and reduce costs for our pharmacy partners.
The U.S. spends more per capita on healthcare than any other country in the world, but it has a high prevalence of diabetes, worse cardiovascular outcomes and lower life expectancy compared to other high-income countries.1 U.S. healthcare costs reached $3.6 trillion in 2018 and spending is anticipated to soar to nearly $6 trillion by 2027.2 However, the U.S. ranks poorly in health system performance.3
READ MORE
Client news
NY Attorney General recognizes MedImpact for assisting in multimillion dollar medicaid FWA investigation.
Fraud, waste, and abuse (FWA) is a national crisis that costs our healthcare system at least $200 billion every year. Even worse, research suggests that only a mere 5% of these losses are recovered.1
READ MORE
We are the PBM that puts clients and consumers first. Always. Ready for a change?